Health & wellness
Johnson & Johnson is working to bring personalized psychiatry to the 7 in 10 people with depression whose treatments aren’t getting the job done.
A condition called fetal and neonatal alloimmune thrombocytopenia (FNAIT) can be deadly in newborns. That’s why Johnson & Johnson is passionate about developing a treatment for the disorder.
The chronic skin condition causes itchy and scaly patches, but it’s much more than simply a cosmetic concern. For World Psoriasis Day, take this quiz to test your psoriasis IQ—and learn why Johnson & Johnson is working on new and more effective treatments for this common autoimmune disease.
They share similar symptoms, sure. But these three distinct conditions have distinct causes, occur in people of varying ages and have their own treatments. Read on for the key differences.
Learn how new technology from Johnson & Johnson aims to be a game-changer not only for patients, but for surgeons, too.
People who identify as LGBTQIA+ are almost three times more likely than their non-LGBTQIA+ counterparts to report poor mental health, but accessing treatment can prove to be challenging. For World Mental Health Day, learn more about the gaps surrounding mental health and how Johnson & Johnson is helping to empower this community.